Quantcast

Tag Archives: pfizer

Carroll Co. man accepts plea deal in wife’s shooting, alleges violent behavior caused by Chantix

‘You talk to a psychiatrist, and they will tell you this is bad stuff,’ says Lawrence Greenberg of the smoking cessation aid Chantix, which a client claims led to a psychotic episode during which he shot his wife. ‘It’s great at getting you to stop smoking, but the way it impacts [your system] can make you have these suicidal or homicidal thoughts.’ (Maximilian Franz/The Daily Record)

WESTMINSTER — A Carroll County man who claims a psychotic episode during which he shot his wife was caused by a reaction to the smoking cessation aid Chantix was released from jail Monday after 21 months as part of a ...

Read More »

FDA gives Baltimore firm’s drug ‘orphaned’ status

Gliknik Inc., a privately held biopharmaceutical company based in Baltimore, on Monday announced the FDA granted its autoimmune candidate drug GL-2045 orphan drug designation for Chronic Inflammatory Demyelinating Polyneuropathy, a rare neurological disorder characterized by progressive weakness and impaired sensory ...

Read More »

Pfizer buys Hospira for about $15.2 billion

Pfizer is buying Hospira for approximately $15.23 billion, saying it is a good fit with its established global pharmaceutical business. The buyout will also help Pfizer tap into the growing market for biosimilars, which are cheaper versions of biologic drugs ...

Read More »

Baltimore biotech Gliknik, Pfizer sign accord

Gliknik Inc., of Baltimore, a biotech that develops novel molecular treatments for autoimmune/inflammatory diseases and cancer, said it has entered into an exclusive worldwide licensing agreement with drug-making giant Pfizer Inc. for its pharmaceutical candidate, GL-2045, a potential treatment for a variety of autoimmune diseases.

Read More »